首页>
外国专利>
PREDICTING RESPONSE TO IMMUNOMODULATORY DRUGS (IMIDS) IN MULTIPLE MYELOMA PATIENTS
PREDICTING RESPONSE TO IMMUNOMODULATORY DRUGS (IMIDS) IN MULTIPLE MYELOMA PATIENTS
展开▼
机译:预测多发性骨髓瘤患者对免疫调节药物(IMID)的反应
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present disclosure relates to methods and kits for classifying an individual afflicted with multiple myeloma based on the likelihood of response to immunomodulatory drugs (IMiDs), such as thalidomide and lenalidomide. The disclosure further relates to methods of treating an individual afflicted with multiple myeloma with an IMiD and with methods for determining a therapy regime based on the likelihood of response to an IMiD as a result of genetic characteristic of the patient.
展开▼